PV26 Speakers

Subject to change.

 

 

image

Jansen Seheult, MB, BCh, BAO, MD

Medical Director, BloodBytes AI Lab, Mayo Clinic


Dr. Jansen Seheult is a Consultant and Assistant Professor in the Divisions of Hematopathology and Computational Pathology & Informatics at Mayo Clinic in Rochester, MN. As Medical Director of the BloodBytes AI Lab, he leads efforts to develop, evaluate, and deploy AI-powered diagnostic workflows for blood cancers. His research focuses on AI, foundation models, and machine learning approaches for lymphoma, bone marrow pathology, and hematologic malignancies.

 

 

SESSIONS

Techcyte Preconference Workshop: How Academic and Private Practice Labs Are Approaching AI-Ready Digital Pathology
   Fri, Oct 16
   11:00AM - 11:45AM PT
  Seaport G

Digital pathology is moving beyond image viewing toward integrated, AI-ready workflows that can support a wide range of clinical, operational, and research needs. In this Techcyte-sponsored pre-conference workshop, speakers will share practical perspectives on how digital pathology platforms can support AI deployment across different practice settings. Mayo Clinic speakers will discuss optimizing digital pathology data for storage and AI inference and will discuss LymphoVision, an in-house-developed foundation model, as an example of how academic medical centers are exploring AI within their broader digital pathology strategy. The workshop will also feature Dr. Philip Ferguson of Northwest Arkansas Pathology Associates, who will share a private practice perspective on implementing a digital pathology platform, including considerations for workflow, pathologist adoption, remote review, and selecting technology that can support long-term growth. Together, these perspectives will give attendees a practical look at how digital pathology and AI workflows are being approached in both large academic medical centers and smaller private pathology practices.

 

Learning Objectives:

  1. Compare different approaches to running AI in digital pathology workflows, including in-house models, third-party algorithms, and co-developed solutions.
  2. Identify key platform and workflow considerations for implementing AI-ready digital pathology across academic medical centers and private pathology practices.
  3. Evaluate practical strategies for supporting pathologist adoption, workflow integration, and long-term scalability in digital pathology implementation.
Chat bot